Antimicrobial Peptide AMP-17 Affects Candida albicans by Disrupting Its Cell Wall and Cell Membrane Integrity

References

• Schelenz S, Barnes RA, Barton RC, et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 2015;15:461–474. doi:10.1016/S1473-3099(15)70006-X25771341
   PubMed Web of Science ®Google Scholar
• Seth R, Xess I, Jana M. Diagnosis of invasive fungal infections in children. Indian Pediatr. 2019;56(3):229–236. doi:10.1007/s13312-019-1505-730954996
   PubMed Web of Science ®Google Scholar
• Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11(2):142–151. doi:10.1016/S1473-3099(10)70218-821272794
   PubMed Web of Science ®Google Scholar
• Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence. 2017;8(2):169–185. doi:10.1080/21505594.2016.119630027268286
   PubMed Web of Science ®Google Scholar
• Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Res. 2017;10:249–259. doi:10.2147/IDR.S124918
   PubMed Web of Science ®Google Scholar
• Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737–779.28702763
   PubMed Web of Science ®Google Scholar
• Tonk M, Vilcinskas A. The medical potential of antimicrobial peptides from insects. Curr Top Med Chem. 2017;17(5):554–575. doi:10.2174/156802661666616071312365427411327
   PubMed Web of Science ®Google Scholar
• Sheehan G, Garvey A, Croke M, et al. Innate humoral immune defences in mammals and insects: the same, with differences? Virulence. 2018;9(1):1625–1639. doi:10.1080/21505594.2018.152653130257608
   PubMed Web of Science ®Google Scholar
• Boman HG, Nilsson-Faye I, Paul K, Rasmuson T. Insect immunity I. Characteristics of an inducible cell-free antibacterial reaction in hemolymph of Samia cynthia pupae. Infect Immun. 1974;10(1):136–145. doi:10.1128/IAI.10.1.136-145.19744210336
   PubMed Web of Science ®Google Scholar
• Tang T, Li X, Yang X, et al. Transcriptional response of Musca domestica larvae to bacterial infection. PLoS One. 2014;9(8):1–12.
   Web of Science ®Google Scholar
• Mishra S, Kumar P, Malik A. Evaluation of Beauveria bassiana infection in the hemolymph serum proteins of the housefly, Musca domestica L. (Diptera: muscidae). Environ Sci Pollut Res. 2017;24(31):1–11. doi:10.1007/s11356-017-0193-x
   Web of Science ®Google Scholar
• Ai H, Wang F, Zhang N, Zhang L, Lei C. Antiviral, immunomodulatory, and free radical scavenging activities of a protein-enriched fraction from the larvae of the housefly, Musca domestica. J Insect Sci. 2013;13(112):1–16. doi:10.1673/031.013.1120123879856
   PubMed Web of Science ®Google Scholar
• Ai H, Wang F, Xia Y, Chen X, Lei C. Antioxidant, antifungal and antiviral activities of chitosan from the larvae of housefly, Musca domestica L. Food Chem. 2012;132(1):493–498. doi:10.1016/j.foodchem.2011.11.03326434321
   PubMed Web of Science ®Google Scholar
• Tao W, Jiangfan X, Yingchun Z, et al. Transcriptional responses of Candida albicans to antimicrobial peptide MAF-1A. Front Microbiol. 2017;8:894–904. doi:10.3389/fmicb.2017.0089428567034
   PubMed Web of Science ®Google Scholar
• Xiu JF, Wang T, Wang Y, et al. Histological observation and expression patterns of antimicrobial peptides during fungal infection in Musca domestica (Diptera: muscidae) larvae. Braz Arch Biol Technol. 2016;59(6):1–13.
   Google Scholar
• Guo G, Tao R, Li Y, et al. Identification and characterization of a novel antimicrobial protein from the housefly Musca domestica. Biochem Biophys Res Commun. 2017;490(3):746–752. doi:10.1016/j.bbrc.2017.06.11228645609
   PubMed Web of Science ®Google Scholar
• Li Y, Chang W, Zhang M, et al. Diorcinol D exerts fungicidal action against Candida albicans through cytoplasm membrane destruction and ROS accumulation. PLoS One. 2015;10(6):1–16.
   Web of Science ®Google Scholar
• Weerden NLVD, Bleackley MR, Anderson MA. Properties and mechanisms of action of naturally occurring antifungal peptides. Cell Mol Life Sci. 2013;70(19):3545–3570. doi:10.1007/s00018-013-1260-123381653
   PubMed Web of Science ®Google Scholar
• Cabib E, Arroyo J. How carbohydrates sculpt cells: chemical control of morphogenesis in the yeast cell wall. Nat Rev Microbiol. 2013;11(9):648–655. doi:10.1038/nrmicro309023949603
   PubMed Web of Science ®Google Scholar
• Tsai PW, Yang CY, Chang HT, et al. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS One. 2011;6(3):e17755. doi:10.1371/journal.pone.001775521448240
   PubMed Web of Science ®Google Scholar
• Lee HS, Kim Y. Antifungal activity of Salvia miltiorrhiza against Candida albicans is associated with the alteration of membrane permeability and (1,3)-β-D-glucan synthase activity. J Microbiol Biotechnol. 2015;26(3):610–617. doi:10.4014/jmb.1511.11009
   Web of Science ®Google Scholar
• Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29(9):464–472. doi:10.1016/j.tibtech.2011.05.00121680034
   PubMed Web of Science ®Google Scholar
• Jia F, Wang J, Peng J, et al. The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species. Amino Acids. 2018;50(2):229–239. doi:10.1007/s00726-017-2507-129101485
   PubMed Web of Science ®Google Scholar
• Richardson JP, Moyes DL. Adaptive immune responses to Candida albicans infection. Virulence. 2015;6(4):327–337. doi:10.1080/21505594.2015.100497725607781
   PubMed Web of Science ®Google Scholar
• Cheng SC, Joosten LA, Kullberg BJ, Netea MG, Maurelli AT. Interplay between Candida albicans and the mammalian innate host defense. Infect Immun. 2012;80(4):1304–1313. doi:10.1128/IAI.06146-1122252867
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128. doi:10.4161/viru.2291323302789
   PubMed Web of Science ®Google Scholar
• Ford CB, Funt JM, Abbey D, et al. The evolution of drug resistance in clinical isolates of Candida albicans. Elife. 2015;4:1–27. doi:10.7554/eLife.00662
   Web of Science ®Google Scholar
• Prashant K, Jayachandran K, Suzana S. Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecular. 2018;8(1):1–24.
   Web of Science ®Google Scholar
• Fu DF, Hu JH, Liu XY. Research progress in genetic engineering expression of antimicrobial peptides. China Anim Husbandry Vet Med. 2010;37(9):124–126.
   Google Scholar
• Onishi J, Meinz M, Thompson J, et al. Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors. Antimicrob Agents Chemother. 2000;44(2):368–377. doi:10.1128/AAC.44.2.368-377.200010639364
   PubMed Web of Science ®Google Scholar
• Rautenbach M, Troskie AM, Vosloo JA. Antifungal peptides: to be or not to be membrane active. Biochimie. 2016;130:132–145. doi:10.1016/j.biochi.2016.05.01327234616
   PubMed Web of Science ®Google Scholar
• Jr KK, Kataoka R, Kimura Y, et al. Dynamic structure of biological membranes as probed by 1,6-diphenyl-1,3,5-hexatriene: a nanosecond fluorescence depolarization study. Biochem. 1981;20(15):4270–4277. doi:10.1021/bi00518a0067284326
   PubMed Web of Science ®Google Scholar
• Choi H, Cho J, Jin Q, et al. Antifungal property of dihydrodehydrodiconiferyl alcohol 9-O-β-d-glucoside and its pore-forming action in plasma membrane of Candida albicans. Biochim Biophys Acta Biomembr. 2012;1818(7):1648–1655. doi:10.1016/j.bbamem.2012.02.026
   Web of Science ®Google Scholar
• Brewster J, De Valoir T, Dwyer N, et al. An osmosensing signal transduction pathway in yeast. Science. 1993;259(5102):1760–1763. doi:10.1126/science.76812207681220
   PubMed Web of Science ®Google Scholar
• Gregori C, Schuller C, Roetzer A, et al. The high-osmolarity glycerol response pathway in the human fungal pathogen Candida glabrata strain ATCC 2001 lacks a signaling branch that operates in Baker’s yeast. Eukaryot Cell. 2007;6(9):1635–1645. doi:10.1128/EC.00106-0717616630
   PubMedGoogle Scholar
• Lee HS, Kim Y. Paeonia lactiflora inhibits cell wall synthesis and triggers membrane depolarization in Candida albicans. J Microbiol Biotech. 2017;27(2):395–404. doi:10.4014/jmb.1611.11064
   Web of Science ®Google Scholar
• Mercer EI. The biosynthesis of ergosterol. Pest Manag Sci. 1984;15(2):133–155. doi:10.1002/ps.2780150206
   Web of Science ®Google Scholar
• Dagan A, Efron L, Gaidukov L, et al. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother. 2002;46(4):1059–1066. doi:10.1128/AAC.46.4.1059-1066.200211897590
   PubMed Web of Science ®Google Scholar